MEDICINE《医学》(可官网投稿)

MEDICINE《医学》(周刊). Medicine is an open access publication, providing authors with continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties. The Medicine review process emphasizes the scientific, technical and ethical validity of submissions. Novelty or potential for impact are not considered during the manuscripts evaluation or adjudication.

杂志简称:medicine
中文译名:《医学》
收录属性:scie(2024版), 目次收录(维普),英文期刊,
自引率:6.60%
投稿方向:医学、medicine, general & internal 医学、内科

MEDICINE《医学》

SCI/E期刊基本信息

出版周期:周刊 地区:美国
中科院分区:4区
是否TOP:非TOP期刊
是否综述:非综述期刊
是否OA:OA期刊
国际标准刊号:ISSN 0025-7974;EISSN1536-5964
杂志语言:英语
出版国家:美国

杂志官网 联系方式

出版地址:TWO COMMERCE SQ,2001 MARKET ST,PHILADELPHIA,USA,PA,19103
杂志邮箱:
投稿网址:https://www.editorialmanager.com/md/default.aspx
杂志官方网址:https://journals.lww.com/md-journal/pages/default.aspx
出版商网址:http://www.lww.com/

杂志投稿要求

投稿须知【杂志社官方网站信息】

Instructions for Authors

About the Journal

Medicine® is an open access publication, providing authors with continuous publication of original research across a broad spectrum of medical scientific disciplines and sub-specialties. The Medicine® review process emphasizes the scientific, technical and ethical validity of submissions. Novelty or potential for impact are not considered during the manuscript's evaluation or adjudication.

Open Access

Open access (OA) is the practice of providing unrestricted access via online to peer-reviewed scholarly research. Open access journals provide 'gold' open access, meaning immediate open access to all their articles on the publisher's website. 'Gold' open access for individual articles is funded by authors (or their author's institution or funders) who pay an open access publishing fee (APC).

The APC for Medicine® is $1650 (USD) for the Creative Commons 4.0 International license for Original Studies published under the and the CCBY-NC license and $1950 for Original Studies published under the CCBY license. The APC for Case Reports and Study Protocols is $1950 and will be published under the CCBY license.

Medicine offers full or partial equitable waivers for accepted articles from low-income and middle-income economies. Eligibility is based on the Research4Life eligibility criteria. Countries listed in Group A are eligible for the full waiver and countries listed in Group B are eligible for the partial (50%) waiver. The waiver is automatically applied based on the Corresponding Author's country information provided during submission.

To determine your eligibility, visit the Research4Life criteria page at https://www.research4life.org/access/criteria/

Scope

Medicine® will publish original research across a broad scope of medical disciplines, including:

Anesthesiology Neurology

Cardiovascular Nutrition

Complementary and alternative medicine Obstetrics and gynecology

Critical care and emergency medicine Oncology

Dermatology Ophthalmology

Endocrinology Oral medicine

Gastroenterology and hepatology Otorhinolaryngology

Genetics Pediatrics

Geriatrics Public Health

Hematology Pulmonology

Immunology Radiology

Infectious Diseases Rheumatology

Mental health Sports and exercise medicine

Metabolic disorders Surgery

Nephrology Toxicology

Neurology Urology

Online Submission

All manuscripts must be submitted online on our Submission Platform.

First-time Users

Please click the Register button on Medicine's Editorial Manager site. Upon registration, you will be sent an email providing your username and password. Save this information for future reference. Note: If you have received an email from us with an assigned username and password, or if you are a repeat user, do not register again. Once you have an assigned username and password, you do not have to re-register.

Authors

Please click the Login button from the menu at the top of the page and login to the system as an author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system.

Editorial and Publishing Policies

Plagiarism

As defined by the World Association of Medical Editors (http://www.wame.org/resources/publication-ethics-policies-for-medical-journals):

Plagiarism is the use of others' published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. The intent and effect of plagiarism is to mislead the reader as to the contributions of the plagiarizer. This applies whether the ideas or words are taken from abstracts, research grant applications, Institutional Review Board applications, or unpublished or published manuscripts in any publication format (print or electronic).

Medicine® is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. iThenticate checks submissions against millions of published research papers, and billions of web content. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting http://www.ithenticate.com.

Plagiarism is scientific misconduct and will be addressed as such. When plagiarism is detected at any time before publication, the Medicine® editorial office will take appropriate action as directed by the standards set forth by the Committee on Publication Ethics (COPE). For additional information, please visit http://www.publicationethics.org.

Ethical Experimentation

The report of any research involving human beings or experimental subjects must be accompanied by a statement to be included in the Additional Information section of the submission process, indicating the mechanism used for reviewing the ethics of the research conducted.

Non-native Speakers of English

Authors who are not native speakers of English who submit manuscripts to international journals often receive negative comments from referees or editors about the English–language usage in their manuscripts, and these problems can contribute to a decision to reject a paper. To help reduce the possibility of such problems, we strongly encourage such authors consider using Wolters Kluwer Author Services***.

Wolters Kluwer Author Services

Wolters Kluwer, in partnership with Editage, offers a unique range of editorial services to help you prepare a submission-ready manuscript. For more information regarding Wolters Kluwer Author Services, please visit http://wkauthorservices.editage.com.

***Note that the use of such a service is at the author's own expense and risk and does not guarantee that the article will be accepted.

Statistical Analysis

For manuscripts that report statistics, the Editor requires that the authors provide evidence of statistical consultation (or at least expertise) by either the inclusion of a statistician/epidemiologist among the authors, or in the acknowledgements; a biostatistician may review such manuscripts during the review process.

In the Methods section:

Identify the statistical tests used to analyze the data.

Indicate the prospectively determined P value that was taken to indicate a significant difference.

Cite only textbook and published article references to support your choices of tests.

Identify any statistics software used. (List software name, version, and company in parentheses in the text, not in the reference list.)

In the Results section:

Note that following the American Medical Association style manual (AMA Manual of Style: A Guide for Authors and Editors, 10th Edition. New York: Oxford University Press; 2007, page 889), the Journal does not use a zero to the left of the decimal point, because "…statistically it is not possible to prove or disprove the null hypothesis completely when only a sample of the population is tested (P cannot equal 0 or 1, except by rounding)."

Report actual P values rather than thresholds: not just whether the P value was above or below the significant-difference threshold. Example: write "P = .18", not "P > .05" or "P = NS."

P should be expressed to 2 digits for P ≥ .01, because expressing P to more than 3 digits does not add useful information. If P < .001, it should be expressed as P < .001, rather than P < .0001 or P = .00001 for example. In certain types of studies, it may be important to express P values to more significant digits. Please consult the AMA Manual of Style for further direction.

If P > .99, P = .999 for example, it should be expressed as P > .99.

Statement of Non-duplication

During the Additional Information section of the submission process, all authors must certify that their manuscript is a unique submission and is not being considered for publication by any other source in any medium. Further, the manuscript has not been published, in part or in full, in any form. Work published or presented as an abstract at a professional meeting will be considered.

Translations

Some previously published translated work may be considered for publication in Medicine®.

Authors must receive approval from the original publication and Medicine® for the translated article to be published.

Authors should indicate in the article that it is a translated article and cite the primary reference.

The translated article should be intended for different group of readers than the primary publication.

Ownership/Permissions

All figures submitted must be owned solely by the author(s). For Figures not meeting this requirement, authors must obtain permission for the use of the figure by Medicine®. Obtaining this permission is the sole responsibility of the author(s). Credit must be included in the figure legend for all figures being printed with permission.

These requirements apply to the following materials:

Previously published materials such as figures and adapted tables or direct quotations of more than 50 words; these require permission from copyright holder (usually the original publisher).

Unpublished data (i.e., from a personal conversation or a manuscript in preparation); these require permission from the appropriate investigator.

Photographs revealing unmasked faces; these require permission from the subject(s) of the photograph.

Product Information

Medications, materials, and devices must be identified by full nonproprietary name as well as brand name if appropriate and the manufacturer's name. Place this information in parentheses in the text, not in a footnote.

Funding Sources

Corresponding Authors are responsible for identifying and declaring all funding sources received for the research submitted to the journal. During submission, Corresponding Authors will also be asked to provide the Funder, Award Number and Grant Recipient. If there are no funders to be identified the corresponding author must state "Funding information is not available." Funding information will be entered during the submission stage and will be included in the final publication.

The Corresponding Author is responsible to completing this on behalf of all authors on the research submitted to the journal and should ensure complete accuracy.

Conflict of Interest

Authors submitting manuscripts to the journal are required to identify any financial interests or affiliations with institutions, organizations, or companies that are mentioned in the manuscript or whose products and services are mentioned in the manuscript, and also any competing interest that could be perceived as a bias in the work. Conflicts of interest can be defined as financial and non-financial in relation to the work.

Authors should disclose any interactions that could be perceived as potential conflicts of interest. This includes grants pertaining to the work and outside of the work that could be perceived as conflicts, revenue paid to the author in relation to the work submitted, payments from a government agency, payments from a pharmaceutical or drug company, personal conflict of interest related to the content of the manuscript, relationships and activities that may have influenced the work, or anything related.

Corresponding authors are responsible for filling this section out for all authors listed on the manuscript. If the corresponding or co-authors does not have a financial or personal conflict of interest relevant to the content of this manuscript, please enter 'the author(s) of this work have nothing to disclose'.

For example:

Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently receiving a grant (#12345) from Organization Y, and is on the speaker's bureau for Organization X – the CME organizers for Company A. For the remaining authors none were declared.

Patient Consent

As per the CARE guidelines, the patient or guardian must provide a written informed consent for inclusion of their clinical and imaging details in the manuscript for the purpose of publication. The submitted manuscript needs to contain a statement that informed consent was obtained from the patient for the purpose of publication. If the patient is deceased, the authors must seek permission from the patient's relatives which must be stated in the submitted manuscript. In cases where permission could not be obtained from the patient or the relatives, the head of the medical team or the institutional review board must take responsibility for the anonymization of the patient and this must be stated in the submitted manuscript. If the informed consent has been waivered by the IRB, the same must be included in the manuscript.

Medicine® provides a patient consent form on the Editorial Manager home page under 'Files and Resources.' Forms signed in a language other than English require a translated form.

Data Availability Statement

Data sharing is encouraged by the journal, but a Data Availability Statement will be required and published with the manuscript. Authors will be provided the following options during submission:

The datasets generated during and/or analyzed during the current study are available in the [NAME] repository, [PERSISTENT WEB LINK TO DATASETS]

The datasets generated during and/or analyzed during the current study are not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

All data generated or analyzed during this study are included in this published article [and its supplementary information files].

The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of [third party name].

Preprints

Medicine® has no objections to considering preprints for publication. If an author is submitting a manuscript that has been shared as a preprint, authors should include the preprint server name and DOI in the Comments section in the Editorial Manager submission.

Authorship

Medicine® adheres to the Authorship Requirements as defined by the International Committee of Medical Journal Editors (ICMJE). For more information, please visit http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html.

Everyone who is listed as an author should have made a substantial, direct, intellectual contribution to the work. For example (in the case of a research report) they should have contributed to the conception, design, analysis and/or interpretation of data.

Honorary or guest authorship is not acceptable.

Co-first authorship and co-corresponding authorship is not acceptable.

Acquisition of funding and provision of technical services, patients, or materials, while they may be essential to the work, are not in themselves sufficient contributions to justify authorship.

Author Name Indexing:

When submitting author names please note that authors should be listed in First Name –Middle Name- Surname order. If an author is submitted as "John R Smith" or "John Robert Smith" the article will publish the authors name as "Smith, J. R."

Be sure to check the proofs prior to publication.

Changes to Authorship

Medicine® considers the final author list to be complete at the time of the first revision submission. Please be sure to check that all authors are properly listed on the revision submission, this includes the spelling of an author's name, their designated degrees, and order of authors listed.

Medicine® has a strict policy on changes to authorship after acceptance of the article and will only consider changes in the most extraordinary situations once the article is accepted.

Author Identification

All submitting Corresponding Authors must provide an ORCID iD when submitting a manuscript to Medicine®. Coauthors are strongly encouraged to provide an ORCID iD but are not required.

Authors can register for an ORCID iD at orcid.org.

刊知网 精心整理,转载请注明出处:https://www.kanzhiwang.com/archives/38779

我要点评 请您把投稿经验分享出来 让大家少走弯路少踩坑,我为人人、人人为我。

内容纠错 您如果发现杂志信息有错漏 可以在下方留言。

上一篇 2024年11月9日 上午11:30
下一篇 2024年11月9日 上午11:30

相关推荐

发表回复

登录后才能评论

评论列表(2条)

  • 李达龙的头像
    李达龙 2024年9月23日 下午4:50

    审稿时间:至今3个月
    文章字数:7000字
    我的职称:中级
    我的学历:硕士
    录用情况:直接录用
    查重要求:20%以下
    是否回复:有自动回复
    投稿主题:临床研究
    期刊点评:看网上说这个sci是个水货期刊,速度快容易中才来的。我从6月初投稿到现在仍然是Under Review,这三个月你知道我是如何过来的吗。是不是玩不起??耽误时间。2020年进入预警期刊,后面解除了预警谁知道啊这么慢,效率不行啊

  • 中了,中了,尔中了A的头像
    我中了 2024年7月19日 下午4:42

    录用情况:直接录用
    期刊点评:投稿清单是什么,不上传这个无法继续,有知道的吗

联系我们

191 1833 1195

在线咨询: QQ交谈

邮件:321628655@qq.com

工作时间:周一至周五,9:30-18:30,节假日休息